Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pparg
|
ENSMUSG00000000440.6 | peroxisome proliferator activated receptor gamma |
Rxrg
|
ENSMUSG00000015843.4 | retinoid X receptor gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_115408242_115408403 | Pparg | 13744 | 0.203766 | 0.94 | 4.9e-03 | Click! |
chr6_115421079_115421237 | Pparg | 908 | 0.616187 | 0.84 | 3.4e-02 | Click! |
chr6_115313528_115313699 | Pparg | 47338 | 0.118055 | 0.74 | 9.3e-02 | Click! |
chr6_115360751_115360913 | Pparg | 119 | 0.972400 | 0.67 | 1.4e-01 | Click! |
chr6_115418714_115419284 | Pparg | 3067 | 0.274937 | 0.61 | 2.0e-01 | Click! |
chr1_167618106_167618290 | Rxrg | 111 | 0.978775 | 0.89 | 1.9e-02 | Click! |
chr1_167649230_167649384 | Rxrg | 30998 | 0.194784 | 0.87 | 2.5e-02 | Click! |
chr1_167645020_167645189 | Rxrg | 26795 | 0.208766 | -0.84 | 3.7e-02 | Click! |
chr1_167618305_167618516 | Rxrg | 101 | 0.980027 | 0.74 | 9.0e-02 | Click! |
chr1_167637133_167637288 | Rxrg | 18901 | 0.234072 | -0.63 | 1.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_125814301_125814474 | 5.04 |
D430042O09Rik |
RIKEN cDNA D430042O09 gene |
15280 |
0.25 |
chr4_141347370_141347546 | 4.41 |
Gm13074 |
predicted gene 13074 |
356 |
0.71 |
chr17_86661961_86662112 | 4.37 |
Gm18832 |
predicted gene, 18832 |
23460 |
0.19 |
chr7_143599041_143599206 | 4.36 |
Cars |
cysteinyl-tRNA synthetase |
558 |
0.5 |
chr6_86129871_86130022 | 4.28 |
Gm19596 |
predicted gene, 19596 |
17206 |
0.14 |
chr15_95767994_95768168 | 4.02 |
Gm8849 |
predicted gene 8849 |
7673 |
0.12 |
chr8_46387074_46387264 | 3.97 |
Gm45253 |
predicted gene 45253 |
1281 |
0.38 |
chr8_106266437_106266607 | 3.64 |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral |
14456 |
0.14 |
chr1_39813213_39813385 | 3.61 |
Gm3646 |
predicted gene 3646 |
7967 |
0.21 |
chr10_61337527_61337708 | 3.58 |
Pald1 |
phosphatase domain containing, paladin 1 |
4710 |
0.15 |
chr2_25156341_25156504 | 3.50 |
Gm13387 |
predicted gene 13387 |
11026 |
0.07 |
chr13_80897778_80898046 | 3.48 |
Arrdc3 |
arrestin domain containing 3 |
7394 |
0.16 |
chr1_39784676_39784852 | 3.44 |
Gm3646 |
predicted gene 3646 |
20568 |
0.18 |
chr15_79234881_79235032 | 3.36 |
Pick1 |
protein interacting with C kinase 1 |
5254 |
0.1 |
chr2_57302912_57303068 | 3.28 |
Gm13535 |
predicted gene 13535 |
27304 |
0.16 |
chr7_132616966_132617405 | 3.23 |
Lhpp |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
3589 |
0.19 |
chr4_137510210_137510361 | 3.13 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
12174 |
0.15 |
chr11_98766772_98767040 | 3.13 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3520 |
0.12 |
chr9_120731019_120731170 | 3.08 |
Gm47064 |
predicted gene, 47064 |
20049 |
0.12 |
chr12_3859666_3859904 | 3.04 |
Dnmt3a |
DNA methyltransferase 3A |
1236 |
0.41 |
chr10_61327652_61327821 | 3.04 |
Pald1 |
phosphatase domain containing, paladin 1 |
14591 |
0.12 |
chr18_11858199_11858406 | 3.00 |
Cables1 |
CDK5 and Abl enzyme substrate 1 |
14002 |
0.16 |
chr12_21148893_21149070 | 2.96 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
37027 |
0.15 |
chr8_121351760_121351911 | 2.95 |
Gm26815 |
predicted gene, 26815 |
5001 |
0.24 |
chr5_139358617_139359046 | 2.93 |
Cyp2w1 |
cytochrome P450, family 2, subfamily w, polypeptide 1 |
4255 |
0.13 |
chr3_55311701_55311852 | 2.92 |
Gm25132 |
predicted gene, 25132 |
6459 |
0.19 |
chr19_5028205_5028356 | 2.91 |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
2103 |
0.12 |
chr2_3771544_3771776 | 2.82 |
Fam107b |
family with sequence similarity 107, member B |
952 |
0.57 |
chr6_59415921_59416327 | 2.82 |
Gprin3 |
GPRIN family member 3 |
10170 |
0.3 |
chr11_23858437_23858588 | 2.82 |
Papolg |
poly(A) polymerase gamma |
9958 |
0.19 |
chr2_152359606_152359999 | 2.82 |
Gm14165 |
predicted gene 14165 |
6187 |
0.1 |
chr14_64441838_64442032 | 2.73 |
Msra |
methionine sulfoxide reductase A |
1018 |
0.64 |
chr3_96820328_96820503 | 2.72 |
Cd160 |
CD160 antigen |
5894 |
0.12 |
chr9_42757123_42757296 | 2.72 |
Grik4 |
glutamate receptor, ionotropic, kainate 4 |
51490 |
0.15 |
chr9_119342839_119343002 | 2.70 |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
147 |
0.91 |
chr17_47588648_47588815 | 2.69 |
Ccnd3 |
cyclin D3 |
4705 |
0.12 |
chr3_69139928_69140109 | 2.67 |
Gm1647 |
predicted gene 1647 |
8785 |
0.14 |
chr4_134067460_134067623 | 2.66 |
Crybg2 |
crystallin beta-gamma domain containing 2 |
911 |
0.42 |
chr7_29251255_29251571 | 2.65 |
2200002D01Rik |
RIKEN cDNA 2200002D01 gene |
2947 |
0.13 |
chr3_95267928_95268183 | 2.65 |
Prune1 |
prune exopolyphosphatase |
889 |
0.34 |
chr10_80766506_80766796 | 2.60 |
Gm17151 |
predicted gene 17151 |
2336 |
0.13 |
chr1_172643169_172643320 | 2.56 |
Dusp23 |
dual specificity phosphatase 23 |
10282 |
0.14 |
chr13_32824374_32824659 | 2.56 |
Wrnip1 |
Werner helicase interacting protein 1 |
3750 |
0.17 |
chr16_95682442_95682895 | 2.53 |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
19407 |
0.21 |
chr10_84901798_84901995 | 2.50 |
Ric8b |
RIC8 guanine nucleotide exchange factor B |
15720 |
0.22 |
chr10_8195740_8196032 | 2.49 |
Gm30906 |
predicted gene, 30906 |
19755 |
0.25 |
chr5_36043248_36043399 | 2.48 |
Afap1 |
actin filament associated protein 1 |
56318 |
0.14 |
chr6_121890040_121890777 | 2.47 |
Mug1 |
murinoglobulin 1 |
4831 |
0.21 |
chr4_62508801_62509208 | 2.46 |
Hdhd3 |
haloacid dehalogenase-like hydrolase domain containing 3 |
5537 |
0.12 |
chr2_33446915_33447078 | 2.46 |
Gm13536 |
predicted gene 13536 |
194 |
0.93 |
chr6_86636554_86636720 | 2.43 |
Asprv1 |
aspartic peptidase, retroviral-like 1 |
8473 |
0.11 |
chr10_80966373_80966536 | 2.42 |
Gm3828 |
predicted gene 3828 |
11744 |
0.09 |
chr4_135958514_135958691 | 2.42 |
Hmgcl |
3-hydroxy-3-methylglutaryl-Coenzyme A lyase |
1125 |
0.29 |
chr4_46867682_46867844 | 2.41 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
7861 |
0.27 |
chr11_88852910_88853083 | 2.40 |
4930556N13Rik |
RIKEN cDNA 4930556N13 gene |
1392 |
0.3 |
chr1_39826010_39826174 | 2.39 |
1700066B17Rik |
RIKEN cDNA 1700066B17 gene |
19607 |
0.18 |
chr18_11851878_11852035 | 2.38 |
Cables1 |
CDK5 and Abl enzyme substrate 1 |
7656 |
0.17 |
chr8_46499865_46500163 | 2.36 |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
7182 |
0.16 |
chr10_83244234_83244393 | 2.35 |
Slc41a2 |
solute carrier family 41, member 2 |
60062 |
0.11 |
chr1_133190582_133190733 | 2.35 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
9336 |
0.18 |
chr13_31897681_31897843 | 2.34 |
Gm11380 |
predicted gene 11380 |
13537 |
0.21 |
chr7_19952685_19952933 | 2.33 |
Rpl7a-ps8 |
ribosomal protein L7A, pseudogene 8 |
974 |
0.29 |
chr15_67018812_67018971 | 2.33 |
Gm31342 |
predicted gene, 31342 |
21167 |
0.18 |
chr9_32519674_32519894 | 2.31 |
Gm37474 |
predicted gene, 37474 |
7174 |
0.12 |
chr9_106452941_106453115 | 2.30 |
Gm28959 |
predicted gene 28959 |
110 |
0.68 |
chr2_25431594_25431764 | 2.28 |
Abca2 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
2976 |
0.1 |
chr5_134170212_134170373 | 2.26 |
Rcc1l |
reculator of chromosome condensation 1 like |
917 |
0.46 |
chr7_84117939_84118128 | 2.25 |
Abhd17c |
abhydrolase domain containing 17C |
29782 |
0.13 |
chr6_86466923_86467074 | 2.24 |
C87436 |
expressed sequence C87436 |
2958 |
0.12 |
chr3_145834049_145834216 | 2.24 |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
23653 |
0.18 |
chr15_99716487_99716652 | 2.24 |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
946 |
0.3 |
chr6_147023422_147023593 | 2.24 |
Gm35876 |
predicted gene, 35876 |
4494 |
0.14 |
chr6_94317117_94317268 | 2.24 |
Gm44307 |
predicted gene, 44307 |
6842 |
0.22 |
chr2_179503121_179503284 | 2.20 |
Cdh4 |
cadherin 4 |
58969 |
0.13 |
chr11_115212363_115212520 | 2.18 |
Nat9 |
N-acetyltransferase 9 (GCN5-related, putative) |
24582 |
0.09 |
chr6_71836427_71836590 | 2.18 |
Gm44771 |
predicted gene 44771 |
4798 |
0.12 |
chr10_75835336_75835679 | 2.18 |
Gstt2 |
glutathione S-transferase, theta 2 |
626 |
0.54 |
chr5_62305708_62305881 | 2.18 |
Gm43238 |
predicted gene 43238 |
122925 |
0.06 |
chr10_61341072_61341225 | 2.17 |
Pald1 |
phosphatase domain containing, paladin 1 |
1179 |
0.37 |
chr3_9599812_9599994 | 2.17 |
Zfp704 |
zinc finger protein 704 |
10182 |
0.23 |
chr10_80086998_80087176 | 2.17 |
Sbno2 |
strawberry notch 2 |
11648 |
0.09 |
chr2_31891353_31891524 | 2.16 |
Gm13441 |
predicted gene 13441 |
979 |
0.45 |
chrX_85784021_85784178 | 2.14 |
Gm14766 |
predicted gene 14766 |
6774 |
0.14 |
chr13_48317548_48317729 | 2.14 |
Gm8588 |
predicted gene 8588 |
4968 |
0.19 |
chr18_8812577_8812728 | 2.14 |
Gm26119 |
predicted gene, 26119 |
114296 |
0.06 |
chr18_12882054_12882208 | 2.12 |
Osbpl1a |
oxysterol binding protein-like 1A |
2154 |
0.28 |
chr14_61327766_61327947 | 2.11 |
Gm5461 |
predicted gene 5461 |
2046 |
0.2 |
chr16_35635109_35635270 | 2.11 |
Sema5b |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B |
22906 |
0.17 |
chr2_181091052_181091203 | 2.11 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
4294 |
0.17 |
chr7_71704948_71705119 | 2.11 |
Gm44688 |
predicted gene 44688 |
1043 |
0.49 |
chr12_112131117_112131272 | 2.11 |
Mir203 |
microRNA 203 |
314 |
0.84 |
chr12_113118261_113118412 | 2.11 |
Mta1 |
metastasis associated 1 |
12996 |
0.1 |
chr16_22131392_22131565 | 2.11 |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
5731 |
0.21 |
chr10_84754277_84754460 | 2.10 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
1694 |
0.42 |
chr1_155063987_155064316 | 2.09 |
Gm29282 |
predicted gene 29282 |
6972 |
0.17 |
chr17_6018338_6018665 | 2.09 |
Synj2 |
synaptojanin 2 |
4952 |
0.19 |
chr17_84074449_84074742 | 2.08 |
4933433H22Rik |
RIKEN cDNA 4933433H22 gene |
4065 |
0.18 |
chr6_145745302_145745496 | 2.06 |
Gm15704 |
predicted gene 15704 |
874 |
0.51 |
chrX_56606636_56606787 | 2.06 |
Slc9a6 |
solute carrier family 9 (sodium/hydrogen exchanger), member 6 |
3046 |
0.2 |
chr8_120373726_120373901 | 2.05 |
Gm22715 |
predicted gene, 22715 |
69736 |
0.09 |
chr7_133315419_133315795 | 2.04 |
Gm45672 |
predicted gene 45672 |
17594 |
0.25 |
chr19_43971247_43971535 | 2.04 |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
2698 |
0.21 |
chr5_145986709_145986916 | 2.03 |
Cyp3a25 |
cytochrome P450, family 3, subfamily a, polypeptide 25 |
4831 |
0.14 |
chr5_17904858_17905085 | 2.03 |
Cd36 |
CD36 molecule |
16170 |
0.26 |
chr1_59892004_59892155 | 2.03 |
Gm37977 |
predicted gene, 37977 |
4390 |
0.17 |
chr8_33902816_33903036 | 2.02 |
Rbpms |
RNA binding protein gene with multiple splicing |
11162 |
0.17 |
chr6_128520713_128520973 | 2.01 |
Pzp |
PZP, alpha-2-macroglobulin like |
5860 |
0.1 |
chr4_138440154_138440340 | 2.01 |
Mul1 |
mitochondrial ubiquitin ligase activator of NFKB 1 |
5524 |
0.14 |
chr9_108820189_108820340 | 2.00 |
Gm35025 |
predicted gene, 35025 |
4555 |
0.09 |
chr13_97203719_97203882 | 1.99 |
Gm48881 |
predicted gene, 48881 |
825 |
0.55 |
chr11_107703521_107703697 | 1.99 |
Cacng1 |
calcium channel, voltage-dependent, gamma subunit 1 |
12913 |
0.16 |
chr19_53554531_53554692 | 1.99 |
Gm50394 |
predicted gene, 50394 |
24956 |
0.11 |
chr3_9556244_9556399 | 1.98 |
Zfp704 |
zinc finger protein 704 |
8978 |
0.24 |
chr8_117718576_117718739 | 1.97 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
2279 |
0.22 |
chr10_118581468_118581731 | 1.97 |
Ifngas1 |
Ifng antisense RNA 1 |
25074 |
0.2 |
chr8_94529970_94530144 | 1.97 |
Cpne2 |
copine II |
2933 |
0.18 |
chr10_78308725_78308893 | 1.97 |
AC160405.1 |
|
1190 |
0.23 |
chr1_4479698_4479869 | 1.97 |
Sox17 |
SRY (sex determining region Y)-box 17 |
13821 |
0.14 |
chr6_100062035_100062186 | 1.96 |
Gm33201 |
predicted gene, 33201 |
70895 |
0.1 |
chr14_27178259_27178514 | 1.96 |
Gm7591 |
predicted gene 7591 |
32011 |
0.17 |
chr9_120048495_120048762 | 1.95 |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
19655 |
0.08 |
chr2_48441967_48442157 | 1.95 |
Gm13481 |
predicted gene 13481 |
15183 |
0.23 |
chr12_109512584_109512771 | 1.95 |
Gm34081 |
predicted gene, 34081 |
4063 |
0.07 |
chr7_132664967_132665152 | 1.95 |
Gm15582 |
predicted gene 15582 |
5175 |
0.2 |
chr12_72767754_72768100 | 1.95 |
Ppm1a |
protein phosphatase 1A, magnesium dependent, alpha isoform |
6612 |
0.2 |
chr12_8840895_8841077 | 1.95 |
9930038B18Rik |
RIKEN cDNA 9930038B18 gene |
36396 |
0.14 |
chr3_97337526_97337699 | 1.95 |
Bcl9 |
B cell CLL/lymphoma 9 |
39695 |
0.14 |
chr11_63880435_63880610 | 1.95 |
Hmgb1-ps3 |
high mobility group box 1, pseudogene 3 |
33704 |
0.16 |
chr10_80332281_80332447 | 1.94 |
Reep6 |
receptor accessory protein 6 |
2162 |
0.11 |
chr7_45264516_45264678 | 1.94 |
Slc6a16 |
solute carrier family 6, member 16 |
3553 |
0.09 |
chr9_67163799_67163959 | 1.94 |
Gm19299 |
predicted gene, 19299 |
30318 |
0.15 |
chr9_47367167_47367507 | 1.94 |
Gm31816 |
predicted gene, 31816 |
1279 |
0.57 |
chr5_120511752_120511921 | 1.94 |
Slc8b1 |
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 |
566 |
0.62 |
chr1_72726059_72726214 | 1.93 |
Rpl37a |
ribosomal protein L37a |
14355 |
0.15 |
chr7_25025951_25026132 | 1.93 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
20083 |
0.09 |
chr9_74931997_74932158 | 1.93 |
Fam214a |
family with sequence similarity 214, member A |
20807 |
0.17 |
chr4_106854346_106854497 | 1.92 |
Gm12746 |
predicted gene 12746 |
6501 |
0.2 |
chr2_157550429_157550705 | 1.92 |
Gm14286 |
predicted gene 14286 |
5098 |
0.12 |
chr8_69063559_69063737 | 1.92 |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
11860 |
0.15 |
chr5_31036629_31036808 | 1.92 |
Slc5a6 |
solute carrier family 5 (sodium-dependent vitamin transporter), member 6 |
1276 |
0.28 |
chr12_83582014_83582393 | 1.91 |
Zfyve1 |
zinc finger, FYVE domain containing 1 |
13484 |
0.14 |
chr5_139757138_139757304 | 1.91 |
Ints1 |
integrator complex subunit 1 |
2243 |
0.21 |
chr15_34510659_34511041 | 1.91 |
Pop1 |
processing of precursor 1, ribonuclease P/MRP family, (S. cerevisiae) |
943 |
0.43 |
chr15_82670462_82670884 | 1.91 |
Cyp2d36-ps |
cytochrome P450, family 2, subfamily d, polypeptide 36, pseudogene |
12584 |
0.08 |
chr4_149923540_149923724 | 1.90 |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
1161 |
0.44 |
chr17_56168507_56168840 | 1.90 |
Gm44397 |
predicted gene, 44397 |
3452 |
0.11 |
chr17_13663520_13663728 | 1.89 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
5267 |
0.17 |
chr6_82039277_82039610 | 1.89 |
Eva1a |
eva-1 homolog A (C. elegans) |
1600 |
0.34 |
chr13_92924657_92924818 | 1.88 |
Gm31630 |
predicted gene, 31630 |
26451 |
0.21 |
chr6_147955095_147955255 | 1.88 |
Far2 |
fatty acyl CoA reductase 2 |
92084 |
0.07 |
chr5_63964660_63964830 | 1.88 |
Rell1 |
RELT-like 1 |
4078 |
0.19 |
chr11_95827181_95827378 | 1.88 |
Phospho1 |
phosphatase, orphan 1 |
2779 |
0.15 |
chr9_53607367_53607538 | 1.87 |
Acat1 |
acetyl-Coenzyme A acetyltransferase 1 |
2878 |
0.2 |
chr5_30172190_30172367 | 1.87 |
Mir1960 |
microRNA 1960 |
1539 |
0.26 |
chr12_104414666_104414826 | 1.86 |
Gm24334 |
predicted gene, 24334 |
4654 |
0.15 |
chr5_139796267_139796438 | 1.86 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
1162 |
0.36 |
chr6_17172773_17172927 | 1.85 |
Gm4876 |
predicted gene 4876 |
1017 |
0.58 |
chr10_80963823_80963984 | 1.85 |
Gm3828 |
predicted gene 3828 |
9193 |
0.1 |
chr12_110044398_110044582 | 1.84 |
Gm47187 |
predicted gene, 47187 |
17780 |
0.11 |
chr12_116772199_116772372 | 1.84 |
Gm48119 |
predicted gene, 48119 |
80817 |
0.1 |
chr11_4466199_4466376 | 1.84 |
Mtmr3 |
myotubularin related protein 3 |
22079 |
0.16 |
chr15_77077850_77078204 | 1.84 |
1700109K24Rik |
RIKEN cDNA 1700109K24 gene |
6371 |
0.11 |
chr4_134307370_134307538 | 1.83 |
Trim63 |
tripartite motif-containing 63 |
7666 |
0.1 |
chr1_105105311_105105520 | 1.83 |
Gm29012 |
predicted gene 29012 |
11039 |
0.27 |
chr7_126260333_126260533 | 1.83 |
Sbk1 |
SH3-binding kinase 1 |
11571 |
0.11 |
chr5_36464924_36465087 | 1.83 |
Grpel1 |
GrpE-like 1, mitochondrial |
7 |
0.66 |
chr5_64326507_64326669 | 1.83 |
Gm6044 |
predicted gene 6044 |
6332 |
0.16 |
chr12_111949013_111949164 | 1.83 |
Gm36757 |
predicted gene, 36757 |
1429 |
0.26 |
chr5_12476907_12477068 | 1.83 |
Gm8925 |
predicted gene 8925 |
2641 |
0.3 |
chr11_120571836_120572008 | 1.83 |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
919 |
0.27 |
chr2_155266982_155267148 | 1.82 |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
9232 |
0.16 |
chr1_24743279_24743468 | 1.82 |
Lmbrd1 |
LMBR1 domain containing 1 |
1500 |
0.46 |
chr6_88254247_88254414 | 1.81 |
1700031F10Rik |
RIKEN cDNA 1700031F10 gene |
28652 |
0.12 |
chr7_19950777_19950944 | 1.81 |
Igsf23 |
immunoglobulin superfamily, member 23 |
104 |
0.9 |
chr4_115514001_115514407 | 1.81 |
Cyp4a10 |
cytochrome P450, family 4, subfamily a, polypeptide 10 |
4060 |
0.14 |
chr3_38541387_38541538 | 1.81 |
Gm24462 |
predicted gene, 24462 |
16752 |
0.17 |
chr1_180237680_180237869 | 1.81 |
Psen2 |
presenilin 2 |
1448 |
0.33 |
chr6_113656906_113657072 | 1.80 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
11861 |
0.07 |
chr5_135054991_135055173 | 1.80 |
Gm25492 |
predicted gene, 25492 |
966 |
0.29 |
chr11_6276572_6276735 | 1.80 |
Tmed4 |
transmembrane p24 trafficking protein 4 |
1783 |
0.21 |
chr12_24757500_24757664 | 1.80 |
Gm48895 |
predicted gene, 48895 |
2643 |
0.17 |
chr17_29513002_29513355 | 1.79 |
Gm17657 |
predicted gene, 17657 |
6612 |
0.11 |
chr9_116947417_116947569 | 1.79 |
Gm18489 |
predicted gene, 18489 |
111665 |
0.07 |
chr14_103087898_103088058 | 1.79 |
Fbxl3 |
F-box and leucine-rich repeat protein 3 |
1839 |
0.28 |
chr5_135187024_135187335 | 1.79 |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
85 |
0.95 |
chr12_79292996_79293163 | 1.79 |
Zfyve26 |
zinc finger, FYVE domain containing 26 |
3193 |
0.23 |
chr11_59972001_59972167 | 1.78 |
Pemt |
phosphatidylethanolamine N-methyltransferase |
574 |
0.65 |
chr3_152091714_152091865 | 1.78 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
11065 |
0.14 |
chr18_11858447_11858616 | 1.78 |
Cables1 |
CDK5 and Abl enzyme substrate 1 |
14231 |
0.16 |
chr7_79780965_79781281 | 1.78 |
Gm44705 |
predicted gene 44705 |
9502 |
0.09 |
chr9_55225732_55226034 | 1.77 |
Fbxo22 |
F-box protein 22 |
12220 |
0.16 |
chr8_115971471_115971630 | 1.77 |
Gm45733 |
predicted gene 45733 |
521 |
0.88 |
chr3_96575516_96575667 | 1.77 |
Gm16253 |
predicted gene 16253 |
1393 |
0.19 |
chr5_16315940_16316121 | 1.77 |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
9955 |
0.24 |
chr2_137156125_137156303 | 1.77 |
Jag1 |
jagged 1 |
39570 |
0.17 |
chr15_68399262_68399413 | 1.76 |
Gm20732 |
predicted gene 20732 |
36161 |
0.13 |
chr8_115562403_115562562 | 1.76 |
4930488N15Rik |
RIKEN cDNA 4930488N15 gene |
22910 |
0.22 |
chr2_158359823_158359991 | 1.76 |
Gm23925 |
predicted gene, 23925 |
21 |
0.92 |
chr14_37028057_37028234 | 1.75 |
Gm47885 |
predicted gene, 47885 |
3611 |
0.19 |
chr1_171223927_171224083 | 1.75 |
Apoa2 |
apolipoprotein A-II |
1049 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.1 | 3.3 | GO:0006868 | glutamine transport(GO:0006868) |
1.0 | 3.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.8 | 4.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.8 | 2.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.7 | 2.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.7 | 2.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 2.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.6 | 2.5 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.6 | 1.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.6 | 4.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 2.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.6 | 1.7 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.6 | 1.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.6 | 1.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 1.6 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.5 | 2.7 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.5 | 3.2 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.5 | 2.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 2.6 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.5 | 2.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 1.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.5 | 2.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 1.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.5 | 1.5 | GO:1902896 | terminal web assembly(GO:1902896) |
0.5 | 1.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 1.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.5 | 1.5 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.5 | 2.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.5 | 1.9 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.5 | 1.4 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.5 | 1.4 | GO:0003166 | bundle of His development(GO:0003166) |
0.5 | 2.8 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.5 | 1.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 1.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 1.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 2.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 1.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.4 | 0.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 1.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 1.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 1.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 3.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 0.8 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.4 | 1.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 3.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 1.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 1.2 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 2.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 1.6 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.4 | 0.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 6.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 0.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.4 | 0.4 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.4 | 1.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.4 | 1.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 1.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.4 | 1.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 1.9 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.4 | 1.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 2.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
0.4 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.1 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 1.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 1.4 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.3 | 1.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 0.7 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.3 | 1.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 0.7 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.3 | 1.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 1.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 1.7 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.3 | 2.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 0.3 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.3 | 1.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 1.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 1.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 1.3 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 1.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.3 | 1.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 1.0 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 1.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 1.3 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.3 | 2.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 0.9 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.3 | 1.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.9 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.3 | 1.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.3 | 1.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.3 | 1.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 0.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.3 | 0.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 0.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 1.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 0.9 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 0.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 2.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.3 | 0.3 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.3 | 2.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 0.9 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 0.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 2.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 0.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.3 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 0.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 1.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.6 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 0.3 | GO:0015879 | carnitine transport(GO:0015879) |
0.3 | 0.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.3 | 1.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 1.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.3 | 1.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 0.6 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.3 | 1.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.3 | 1.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.3 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 0.5 | GO:0090009 | primitive streak formation(GO:0090009) |
0.3 | 2.4 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.3 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 1.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 0.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.3 | 1.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 0.8 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 1.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 0.8 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 2.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.3 | 1.6 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.3 | 1.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 1.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 2.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 0.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 1.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 2.0 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.3 | 0.3 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 0.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 0.3 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.3 | 0.8 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 1.0 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 0.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.3 | 1.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 1.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 1.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 1.0 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.2 | 1.5 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 1.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.2 | 1.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 0.7 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 1.7 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.5 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.2 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.7 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.2 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.5 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 0.2 | GO:0097531 | mast cell migration(GO:0097531) |
0.2 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.2 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.2 | 0.5 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 1.9 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.7 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 0.9 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.5 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.7 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 0.7 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.5 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 0.2 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.2 | 0.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.2 | 0.9 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.2 | 0.7 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 0.5 | GO:1901656 | glycoside transport(GO:1901656) |
0.2 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 0.9 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 2.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.7 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 0.7 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.7 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.2 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.9 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.7 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 1.7 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.2 | 0.6 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 1.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 1.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 4.7 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.2 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 1.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 1.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 1.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 1.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.6 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 2.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 1.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.2 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 | 0.2 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.2 | 0.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.2 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.2 | 2.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.8 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 1.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 1.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 0.2 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 2.2 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 1.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 1.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.2 | 0.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 1.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 1.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.9 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.4 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.6 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 1.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.2 | GO:0070873 | regulation of polysaccharide metabolic process(GO:0032881) regulation of glycogen metabolic process(GO:0070873) |
0.2 | 0.9 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.7 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 1.7 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.2 | 0.7 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 2.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.9 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 1.3 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 1.7 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 1.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 1.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.2 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.2 | 1.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 1.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 4.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 0.4 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.5 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.5 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.4 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.2 | 0.7 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 0.7 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 0.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.3 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.2 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 1.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.8 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.2 | 1.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 0.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.5 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.2 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.2 | 0.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 0.7 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 2.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.2 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 1.0 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.7 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.3 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 0.6 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 0.5 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.2 | 0.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.5 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 0.3 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.5 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.3 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 0.9 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.5 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.5 | GO:0030325 | adrenal gland development(GO:0030325) |
0.2 | 1.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 1.2 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.6 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.8 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 1.8 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.3 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.2 | 1.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 1.4 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 2.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 0.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 1.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 1.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.9 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.2 | 1.1 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.1 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.1 | 1.6 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.1 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.1 | 0.4 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.3 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.9 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.9 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.4 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.1 | GO:1903897 | PERK-mediated unfolded protein response(GO:0036499) regulation of PERK-mediated unfolded protein response(GO:1903897) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.1 | 0.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.6 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 1.9 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.3 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.4 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.7 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.8 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 2.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.3 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 1.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 3.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 1.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.3 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.7 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.1 | 0.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 2.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.4 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.1 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.3 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 0.5 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.1 | 0.4 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.1 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.3 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.9 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.9 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.7 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.6 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.2 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.1 | 0.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 1.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.8 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.3 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 1.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 2.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.1 | 0.2 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.7 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 2.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.2 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.1 | 0.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.1 | 0.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.2 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.1 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.7 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 1.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 1.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.9 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.6 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.5 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 1.6 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 0.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.2 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 1.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 1.4 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 1.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 2.1 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.2 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.1 | 0.4 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.9 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.4 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.7 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 2.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.4 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.2 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.2 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.2 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 1.1 | GO:0006026 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 0.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.6 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 3.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.5 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 1.2 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.3 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.3 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 1.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.1 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.1 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 1.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 1.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.7 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.1 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 2.5 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.5 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.5 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.1 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.4 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.1 | 0.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.1 | 0.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 1.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.1 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.3 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 1.7 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.1 | 0.6 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.2 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 1.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.1 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.1 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.5 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.5 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.1 | 0.2 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.3 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 1.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 2.2 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.6 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.1 | 0.3 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.5 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 1.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.6 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.2 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.5 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.2 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 1.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.7 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.2 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.1 | 0.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.1 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.5 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 0.4 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.1 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.1 | 0.6 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 0.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.2 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 4.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 1.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.9 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.4 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.1 | 0.1 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.1 | 0.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.2 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.5 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.7 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.5 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 0.5 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.2 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 0.4 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.6 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.1 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.1 | 0.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.7 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.1 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.1 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 1.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.3 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 1.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.6 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.2 | GO:0036230 | granulocyte activation(GO:0036230) |
0.1 | 0.6 | GO:0071357 | cellular response to type I interferon(GO:0071357) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.2 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.1 | 0.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.6 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.2 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.0 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.0 | 0.0 | GO:0035989 | tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.1 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.0 | 0.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 1.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.8 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 1.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.0 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 2.1 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 1.0 | GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process(GO:0030804) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.0 | 0.2 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.0 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.0 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.0 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.2 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.4 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.0 | 0.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 1.9 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.1 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.9 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.0 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.2 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.0 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.2 | GO:0051647 | nucleus localization(GO:0051647) |
0.0 | 0.4 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
0.0 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.0 | 0.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 1.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.3 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.2 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.0 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 1.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.3 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.2 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 1.5 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.2 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.0 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.0 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.0 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.0 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.0 | GO:0021545 | cranial nerve development(GO:0021545) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.0 | 0.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.0 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0001807 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
0.0 | 0.3 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.0 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.0 | GO:0006901 | vesicle coating(GO:0006901) |
0.0 | 0.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:0060572 | morphogenesis of an epithelial bud(GO:0060572) |
0.0 | 0.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.0 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.3 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.0 | 0.1 | GO:0021536 | diencephalon development(GO:0021536) |
0.0 | 0.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.0 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.0 | 0.1 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.6 | 1.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.6 | 1.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.6 | 1.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 1.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 3.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 2.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 1.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 1.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.4 | 1.5 | GO:1903349 | omegasome membrane(GO:1903349) |
0.4 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 3.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 2.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.3 | 1.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 1.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 1.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 1.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 0.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 1.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 2.3 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 0.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 1.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 1.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 4.4 | GO:0001741 | XY body(GO:0001741) |
0.3 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 0.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.0 | GO:0005767 | secondary lysosome(GO:0005767) |
0.2 | 1.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.0 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.7 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 2.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.7 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 2.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 0.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 3.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.9 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.9 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 0.7 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.5 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 1.1 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 2.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.8 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 2.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.9 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 1.9 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.4 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 2.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 1.3 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.3 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 3.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 2.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 2.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 3.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.2 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 2.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 1.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.6 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 1.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 2.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 2.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.4 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 1.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.8 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 5.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 1.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.8 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 2.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 1.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 1.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 3.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 1.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.9 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 4.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 2.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 1.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 8.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 4.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 3.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 3.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 1.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 5.2 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 0.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.2 | GO:0098554 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) lumenal side of membrane(GO:0098576) |
0.1 | 0.2 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 1.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 1.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.5 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 5.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 1.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 1.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 4.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 2.3 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.0 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 2.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0005818 | aster(GO:0005818) |
0.0 | 0.3 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.4 | GO:0097346 | Ino80 complex(GO:0031011) INO80-type complex(GO:0097346) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 4.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.0 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 1.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 2.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.0 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.6 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 1.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.7 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.3 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 1.0 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.6 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 13.0 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 1.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 4.5 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 2.4 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.2 | 3.5 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.1 | 4.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.9 | 3.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.8 | 6.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 2.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 2.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 1.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.6 | 2.2 | GO:0009374 | biotin binding(GO:0009374) |
0.5 | 2.7 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.5 | 1.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.5 | 1.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 3.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 2.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 3.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.5 | 1.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.4 | 1.3 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 1.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 2.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 1.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 1.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 4.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 2.0 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.4 | 2.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.4 | 1.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 1.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 1.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 1.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 1.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 1.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 2.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.3 | 1.3 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 2.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 0.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 1.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 1.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 0.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 1.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.9 | GO:0052622 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.3 | 2.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 3.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 2.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 1.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 3.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 0.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 1.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 1.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 1.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.3 | 2.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.3 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 0.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 1.0 | GO:0015265 | urea channel activity(GO:0015265) |
0.3 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 1.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 1.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 0.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 0.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 3.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 2.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 0.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 1.0 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.7 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 4.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.7 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.9 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 0.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 2.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 3.4 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 1.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 1.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.6 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 1.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 1.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 1.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 2.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 0.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.6 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.6 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 3.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 0.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 3.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 1.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.6 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 2.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 2.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 4.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 2.9 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 1.4 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 1.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 2.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 2.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 1.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 1.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.1 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 1.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.4 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.5 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.7 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 2.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.5 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.8 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 2.7 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 1.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 5.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.3 | GO:0015556 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 3.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.1 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 1.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 21.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 2.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 1.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 1.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 3.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 1.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.5 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 2.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 2.4 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.3 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 1.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 2.7 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 1.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 1.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 3.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.5 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 1.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 2.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 1.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 4.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.5 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.4 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 1.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 1.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.2 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.2 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 2.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 4.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 1.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 1.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 1.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.5 | GO:0052866 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 1.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 1.0 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 1.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 1.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.0 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 1.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 3.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.6 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 1.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.8 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.0 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.3 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 6.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 5.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.5 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.6 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 3.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 5.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 3.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 1.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 6.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 0.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 4.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 3.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 2.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 6.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 4.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 2.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 3.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 3.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.0 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 11.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 6.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.3 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | PID ARF 3PATHWAY | Arf1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 5.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 5.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.4 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 2.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.3 | 3.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 2.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 3.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 2.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 1.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 2.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 4.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 3.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 4.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 3.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 3.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 3.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 2.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 4.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 3.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 2.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 1.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 3.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 2.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 6.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 2.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 1.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 2.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.9 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 2.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 2.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 3.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 2.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.3 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.1 | 2.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 3.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.9 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 6.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.6 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 1.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 5.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.3 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 4.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 1.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 2.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 2.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 2.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 2.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 1.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.6 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.0 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 1.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.2 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |